TABLE 3.
Sensitivity and Specificity for Cutoffs Identifying All Subjects With Disease
| Outcome | TSB, mg/dL | B/A, mg/g | ||||
|---|---|---|---|---|---|---|
| Cutoff | Sensitivity (95% CIa) | Specificity (95% CI) | Cutoff | Sensitivity (95% CI) | Specificity (95% CI) | |
| AABR RR at admission | 22.7 | 100% (96–100) | 9.3% (4.1–17.5) | 5.6 | 100% (96–100) | 3.5% (0.8–9.9) |
| ABE, maximum BIND 4–9 | 27.0 | 100% (94–100) | 49.2% (40.9.2–58.1) | 6.8 | 100% (94–100) | 26.5% (19.2–34.9) |
| AABR RR at follow-up | 30.7 | 100% (84–100) | 68.9% (59.1–77.7) | 8.5 | 100% (84–100) | 48.5% (38.6–58.6) |
| Kernicterus* | 28.6 | 100% (90–100) | 49.5% (39.5–59.5) | 8.5 | 100% (90–100) | 48.5% (38.6–58.6) |
CI, confidence interval. * including those who died
a
CI Excludes 4 patients admitted at <24 h of age.